These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 30446366)
1. Efficacy, tolerability, and blood concentration of zonisamide in daily clinical practice. Park KM; Lee BI; Shin KJ; Ha SY; Park J; Kim SE; Kim SE J Clin Neurosci; 2019 Mar; 61():44-47. PubMed ID: 30446366 [TBL] [Abstract][Full Text] [Related]
2. The long-term retention of zonisamide in a large cohort of people with epilepsy at a tertiary referral centre. Catarino CB; Bartolini E; Bell GS; Yuen AW; Duncan JS; Sander JW Epilepsy Res; 2011 Sep; 96(1-2):39-44. PubMed ID: 21601427 [TBL] [Abstract][Full Text] [Related]
3. Long-term effects of zonisamide in adult patients with intellectual disability. Eck K; Rauch C; Kerling F; Hamer H; Winterholler M Acta Neurol Scand; 2021 Sep; 144(3):275-282. PubMed ID: 33914900 [TBL] [Abstract][Full Text] [Related]
4. [A retrospective analysis of using zonisamide and retention in monotherapy among patients with epilepsy in routine clinical practice]. Rudakova IG; Belova YA; Kotov AS; Romanova MV Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(11. Vyp. 2):80-87. PubMed ID: 32207736 [TBL] [Abstract][Full Text] [Related]
5. Efficacy, tolerability, and retention rates of zonisamide in older adult patients with focal-onset epilepsy: Experiences from two tertiary epilepsy centers. Doğan EA; Genç E; Genç BO; Erdoğan Ç Epilepsy Behav; 2017 Nov; 76():19-23. PubMed ID: 28927711 [TBL] [Abstract][Full Text] [Related]
6. Changes in cognition after introduction or withdrawal of zonisamide versus topiramate in epilepsy patients: A retrospective study using Bayes statistics. Meschede C; Witt JA; Brömling S; Moskau-Hartmann S; Rademacher M; Surges R; von Wrede R; Helmstaedter C Epilepsia; 2020 Jul; 61(7):1481-1490. PubMed ID: 32557579 [TBL] [Abstract][Full Text] [Related]
7. Retention, dosing, tolerability and patient reported seizure outcome of Zonisamide as only add-on treatment under real-life conditions in adult patients with partial onset seizures: Results of the observational study ZOOM. Hamer H; Baulac M; McMurray R; Kockelmann E Seizure; 2016 Jan; 34():66-73. PubMed ID: 26735004 [TBL] [Abstract][Full Text] [Related]
8. Long-term retention rate of zonisamide in patients with epilepsy: an observational study. Kim DW; Choi K; Moon HS; Oh J Clin Neuropharmacol; 2014; 37(5):133-5. PubMed ID: 25229169 [TBL] [Abstract][Full Text] [Related]
9. Retention rate of zonisamide in intractable epilepsy. Nakken KO; Lindstrøm P; Andersen H Acta Neurol Scand; 2015 May; 131(5):268-74. PubMed ID: 25644477 [TBL] [Abstract][Full Text] [Related]
10. Adverse effects & drug load of antiepileptic drugs in patients with epilepsy: Monotherapy versus polytherapy. Joshi R; Tripathi M; Gupta P; Gulati S; Gupta YK Indian J Med Res; 2017 Mar; 145(3):317-326. PubMed ID: 28749393 [TBL] [Abstract][Full Text] [Related]
11. Efficacy and tolerability of zonisamide in juvenile myoclonic epilepsy. Kothare SV; Valencia I; Khurana DS; Hardison H; Melvin JJ; Legido A Epileptic Disord; 2004 Dec; 6(4):267-70. PubMed ID: 15634623 [TBL] [Abstract][Full Text] [Related]
12. Prospective audits with newer antiepileptic drugs in focal epilepsy: insights into population responses? Brodie MJ; Kelly K; Stephen LJ Epilepsy Behav; 2014 Feb; 31():73-6. PubMed ID: 24361766 [TBL] [Abstract][Full Text] [Related]
13. Management and monitoring of patients treated with zonisamide: the OZONE study. Dupont S; Biraben A; Lavernhe G; Marquet T; Allaf B Epileptic Disord; 2013 Sep; 15(3):278-88. PubMed ID: 23906691 [TBL] [Abstract][Full Text] [Related]
14. Efficacy and tolerability of adjunctive therapy with zonisamide in childhood intractable epilepsy. Lee YJ; Kang HC; Seo JH; Lee JS; Kim HD Brain Dev; 2010 Mar; 32(3):208-12. PubMed ID: 19304420 [TBL] [Abstract][Full Text] [Related]
15. Clinical efficacy and tolerability of zonisamide monotherapy in dogs with newly diagnosed idiopathic epilepsy: Prospective open-label uncontrolled multicenter trial. Saito M; Nomura A; Hasegawa D; Watanabe N; Uchida K; Okuno S; Nakai M; Orito K J Vet Intern Med; 2024; 38(4):2228-2236. PubMed ID: 38780448 [TBL] [Abstract][Full Text] [Related]
16. Comparative retention rates and long-term tolerability of new antiepileptic drugs. Chung S; Wang N; Hank N Seizure; 2007 Jun; 16(4):296-304. PubMed ID: 17267243 [TBL] [Abstract][Full Text] [Related]
17. Relationship between adverse effects of antiepileptic drugs, number of coprescribed drugs, and drug load in a large cohort of consecutive patients with drug-refractory epilepsy. Canevini MP; De Sarro G; Galimberti CA; Gatti G; Licchetta L; Malerba A; Muscas G; La Neve A; Striano P; Perucca E; Epilepsia; 2010 May; 51(5):797-804. PubMed ID: 20545754 [TBL] [Abstract][Full Text] [Related]
18. Could Adult European Pharmacoresistant Epilepsy Patients Be Treated With Higher Doses of Zonisamide? Miro J; Jaraba S; Juvany R; Santurino M; Cobo S; Falip M Clin Neuropharmacol; 2016; 39(3):121-4. PubMed ID: 26818046 [TBL] [Abstract][Full Text] [Related]
19. Efficacy and tolerability of zonisamide as add-on in brain tumor-related epilepsy: preliminary report. Maschio M; Dinapoli L; Saveriano F; Pompili A; Carapella CM; Vidiri A; Jandolo B Acta Neurol Scand; 2009 Sep; 120(3):210-2. PubMed ID: 19719809 [TBL] [Abstract][Full Text] [Related]
20. Open-label, long-term safety study of zonisamide administered to children and adolescents with epilepsy. Shinnar S; Pellock JM; Conry JA Eur J Paediatr Neurol; 2009 Jan; 13(1):3-9. PubMed ID: 18343174 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]